{
  "quoteSummary": {
    "result": [
      {
        "defaultKeyStatistics": {
          "maxAge": 1,
          "priceHint": {
            "raw": 2,
            "fmt": "2",
            "longFmt": "2"
          },
          "enterpriseValue": {
            "raw": 244202496,
            "fmt": "244.2M",
            "longFmt": "244,202,496"
          },
          "forwardPE": {},
          "profitMargins": {
            "raw": 0.00802,
            "fmt": "0.80%"
          },
          "floatShares": {
            "raw": 3193852,
            "fmt": "3.19M",
            "longFmt": "3,193,852"
          },
          "sharesOutstanding": {
            "raw": 7865520,
            "fmt": "7.87M",
            "longFmt": "7,865,520"
          },
          "sharesShort": {},
          "sharesShortPriorMonth": {},
          "heldPercentInsiders": {},
          "heldPercentInstitutions": {},
          "shortRatio": {},
          "shortPercentOfFloat": {},
          "beta": {
            "raw": -0.217341,
            "fmt": "-0.22"
          },
          "morningStarOverallRating": {},
          "morningStarRiskRating": {},
          "category": null,
          "bookValue": {
            "raw": 11.132,
            "fmt": "11.13"
          },
          "priceToBook": {
            "raw": 1.0734818,
            "fmt": "1.07"
          },
          "annualReportExpenseRatio": {},
          "ytdReturn": {},
          "beta3Year": {},
          "totalAssets": {},
          "yield": {},
          "fundFamily": null,
          "fundInceptionDate": {},
          "legalType": null,
          "threeYearAverageReturn": {},
          "fiveYearAverageReturn": {},
          "priceToSalesTrailing12Months": {},
          "lastFiscalYearEnd": {
            "raw": 1490918400,
            "fmt": "2017-03-31"
          },
          "nextFiscalYearEnd": {
            "raw": 1553990400,
            "fmt": "2019-03-31"
          },
          "mostRecentQuarter": {
            "raw": 1514678400,
            "fmt": "2017-12-31"
          },
          "earningsQuarterlyGrowth": {
            "raw": -0.915,
            "fmt": "-91.50%"
          },
          "revenueQuarterlyGrowth": {},
          "netIncomeToCommon": {
            "raw": 1639113,
            "fmt": "1.64M",
            "longFmt": "1,639,113"
          },
          "trailingEps": {
            "raw": 0.206,
            "fmt": "0.21"
          },
          "forwardEps": {},
          "pegRatio": {},
          "lastSplitFactor": null,
          "lastSplitDate": {},
          "enterpriseToRevenue": {
            "raw": 1.196,
            "fmt": "1.20"
          },
          "enterpriseToEbitda": {
            "raw": -17.403,
            "fmt": "-17.40"
          },
          "52WeekChange": {
            "raw": "Infinity",
            "fmt": "\u00e2\u02c6\u017e%"
          },
          "SandP52WeekChange": {
            "raw": 0.12668931,
            "fmt": "12.67%"
          },
          "lastDividendValue": {},
          "lastCapGain": {},
          "annualHoldingsTurnover": {}
        },
        "summaryProfile": {
          "address1": "TGV Mansion",
          "address2": "6-2-1012 3rd Floor Khairatabad",
          "city": "Hyderabad",
          "zip": "500004",
          "country": "India",
          "phone": "91 80 9633 0007",
          "fax": "91 40 2331 0379",
          "website": "http://www.roopaindustries.com",
          "industry": "Chemicals - Major Diversified",
          "sector": "Basic Materials",
          "longBusinessSummary": "Roopa Industries Limited manufactures, sells, and exports nutraceuticals, bulk drugs, and fine chemicals in India, the United States, Japan, and the European Union. The company offers glucosamine, a nutraceutical/nutritional supplement that is used for arthritis treatment; and triphenyl phosphine, which have applications in antibiotics, statins, specialty resins/paints, fire retardants, phosphonium salts, phase transfer catalysts, agriculture related products, etc., as well as in organic synthesis. It also provides bromine and bromine compounds, including meta bromo anisole, tetra butyl ammonium bromide, 1-bromo-3-chloropropane, 1-acetoxy ethyl bromide, etc., which are used in chemical and pharmaceutical industries; esomeprazole magnesium trihydrate that reduces acid secretion through inhibition of H+/K+ATPase in gastric parietal cells; and tamsulosin, an alpha-blocker, which helps in relaxation of bladder and prostate muscles. Roopa Industries Limited was incorporated in 1985 and is based in Hyderabad, India.",
          "fullTimeEmployees": 53,
          "companyOfficers": [],
          "maxAge": 86400
        },
        "financialData": {
          "maxAge": 86400,
          "currentPrice": {
            "raw": 11.95,
            "fmt": "11.95"
          },
          "targetHighPrice": {},
          "targetLowPrice": {},
          "targetMeanPrice": {},
          "targetMedianPrice": {},
          "recommendationMean": {},
          "recommendationKey": "none",
          "numberOfAnalystOpinions": {},
          "totalCash": {
            "raw": 9720000,
            "fmt": "9.72M",
            "longFmt": "9,720,000"
          },
          "totalCashPerShare": {
            "raw": 1.137,
            "fmt": "1.14"
          },
          "ebitda": {
            "raw": -14032008,
            "fmt": "-14.03M",
            "longFmt": "-14,032,008"
          },
          "totalDebt": {
            "raw": 123535000,
            "fmt": "123.53M",
            "longFmt": "123,535,000"
          },
          "quickRatio": {},
          "currentRatio": {},
          "totalRevenue": {
            "raw": 204249856,
            "fmt": "204.25M",
            "longFmt": "204,249,856"
          },
          "debtToEquity": {
            "raw": 132.902,
            "fmt": "132.90"
          },
          "revenuePerShare": {
            "raw": 25.693,
            "fmt": "25.69"
          },
          "returnOnAssets": {},
          "returnOnEquity": {},
          "grossProfits": {
            "raw": 108768181,
            "fmt": "108.77M",
            "longFmt": "108,768,181"
          },
          "freeCashflow": {},
          "operatingCashflow": {},
          "earningsGrowth": {
            "raw": -0.92,
            "fmt": "-92.00%"
          },
          "revenueGrowth": {
            "raw": -0.453,
            "fmt": "-45.30%"
          },
          "grossMargins": {
            "raw": 0.19198,
            "fmt": "19.20%"
          },
          "ebitdaMargins": {
            "raw": -0.0687,
            "fmt": "-6.87%"
          },
          "operatingMargins": {
            "raw": -0.09347,
            "fmt": "-9.35%"
          },
          "profitMargins": {
            "raw": 0.00802,
            "fmt": "0.80%"
          },
          "financialCurrency": "INR"
        }
      }
    ],
    "error": null
  }
}